8月13日，康龙化成盘中上涨3.59%，报30.0港元，成交额3348.93万港元。
消息面上，公司董事会将于8月20日召开会议审议上半年中期业绩。此前公司已预告上半年营收74.72亿至76.65亿元，同比增长16%-19%，新签订单同比增长超30%，其中小分子CDMO新签订单增长超50%。同时CXO板块持续走强，龙头药明康德中期营收同比增长38.93%、净利润增长29.43%，行业景气度延续向好带动板块估值修复。今日同板块药明康德涨1.76%、药明生物涨0.74%、金斯瑞生物科技涨2.25%。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.